Intermediate arylamine compounds
Cirillo, Pier F; Breitfelder, Steffen; Patel, Usha R; Proudfoot, John R; Swinamer, Alan D
Boehringer Ingelheim Pharmaceuticals, Inc.;
Attorney, Agent or Firm:
Morris Michael P. Bottino Anthony P. Datlow Philip I.
Disclosed are novel aromatic compounds which are useful for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are and pharmaceutical compositions containing, intermediate compounds and processes of making such compounds.
Apr 11, 2006
Apr 28, 2003